447 related articles for article (PubMed ID: 17070165)
21. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction.
Kubánek M; Goode KM; Lánská V; Clark AL; Cleland JG
Eur J Heart Fail; 2009 Apr; 11(4):367-77. PubMed ID: 19179406
[TBL] [Abstract][Full Text] [Related]
22. NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure study (SCREEN-HF).
McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Stewart S; Krum H
Int J Cardiol; 2013 Oct; 169(2):133-8. PubMed ID: 24080362
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of different strategies for identifying asymptomatic left ventricular dysfunction and pre-clinical (stage B) heart failure in the elderly. Results from 'PREDICTOR', a population based-study in central Italy.
Mureddu GF; Tarantini L; Agabiti N; Faggiano P; Masson S; Latini R; Cesaroni G; Miceli M; Forastiere F; Scardovi AB; Uguccioni M; Boccanelli A
Eur J Heart Fail; 2013 Oct; 15(10):1102-12. PubMed ID: 23787717
[TBL] [Abstract][Full Text] [Related]
24. N-terminal pro-B-type natriuretic peptide as a diagnostic test for ventricular dysfunction in patients with coronary disease: data from the heart and soul study.
Corteville DC; Bibbins-Domingo K; Wu AH; Ali S; Schiller NB; Whooley MA
Arch Intern Med; 2007 Mar; 167(5):483-9. PubMed ID: 17353496
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
[TBL] [Abstract][Full Text] [Related]
26. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function.
Rothenburger M; Stypmann J; Bruch C; Wichter T; Hoppe M; Drees G; Berendes E; Huelsken G; Loeher A; Welp H; Röttger C; Schmid C; Scheld HH; Tjan TD
J Heart Lung Transplant; 2006 May; 25(5):596-602. PubMed ID: 16678040
[TBL] [Abstract][Full Text] [Related]
27. N-terminal pro-brain natriuretic protein levels in takotsubo cardiomyopathy.
Nguyen TH; Neil CJ; Sverdlov AL; Mahadavan G; Chirkov YY; Kucia AM; Stansborough J; Beltrame JF; Selvanayagam JB; Zeitz CJ; Struthers AD; Frenneaux MP; Horowitz JD
Am J Cardiol; 2011 Nov; 108(9):1316-21. PubMed ID: 21871590
[TBL] [Abstract][Full Text] [Related]
28. N-terminal B-type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: results of the SCReening Evaluationof the Evolution of New-Heart Failure Study (SCREEN-HF).
McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Krum H
Eur J Heart Fail; 2013 May; 15(5):573-80. PubMed ID: 23338855
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
Helal I; Belhadj R; Mohseni A; Bazdeh L; Drissa H; Elyounsi F; Abdallah TB; Abdelmoula J; Kheder A
Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
[TBL] [Abstract][Full Text] [Related]
30. Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide.
Giallauria F; Cirillo P; Lucci R; Pacileo M; De Lorenzo A; D'Agostino M; Moschella S; Psaroudaki M; Del Forno D; Orio F; Vitale DF; Chiariello M; Vigorito C
Eur J Cardiovasc Prev Rehabil; 2008 Feb; 15(1):113-8. PubMed ID: 18277196
[TBL] [Abstract][Full Text] [Related]
31. N-terminal pro-brain natriuretic peptide (NT-proBNP) in Type 2 diabetes with left ventricular dysfunction.
Kim JY; Lee EY; Jee JH; Lee BW; Chung JH; Jeun ES; Min YK; Lee MS; Kim KW; Lee MK
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S238-42. PubMed ID: 17490778
[TBL] [Abstract][Full Text] [Related]
32. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation.
Shelton RJ; Clark AL; Goode K; Rigby AS; Cleland JG
Eur Heart J; 2006 Oct; 27(19):2353-61. PubMed ID: 16952921
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic accuracy of N-terminal pro-brain natriuretic peptide in the evaluation of postoperative left ventricular diastolic dysfunction.
Islamoglu F; Ozcan K; Apaydin AZ; Soydas C; Bayindir O; Durmaz I
Tex Heart Inst J; 2008; 35(2):111-8. PubMed ID: 18612440
[TBL] [Abstract][Full Text] [Related]
34. The detection of left ventricular diastolic dysfunction in hypertensive patients: Performance of N-terminal probrain natriuretic peptide.
Barutçuoglu B; Parildar Z; Başol G; Gürgün C; Tekin Y; Bayindir O
Blood Press; 2010 Aug; 19(4):212-7. PubMed ID: 20070249
[TBL] [Abstract][Full Text] [Related]
35. Pericardial fluid and serum biomarkers equally predict ventricular dysfunction.
Amjad S; Sami SA; Basir MN; Hameed K; Fujita M; Ahmad HR
Asian Cardiovasc Thorac Ann; 2013 Apr; 21(2):160-5. PubMed ID: 24532613
[TBL] [Abstract][Full Text] [Related]
36. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
[TBL] [Abstract][Full Text] [Related]
37. Pro-B-type natriuretic peptide(1-108) circulates in the general community: plasma determinants and detection of left ventricular dysfunction.
Macheret F; Boerrigter G; McKie P; Costello-Boerrigter L; Lahr B; Heublein D; Sandberg S; Ikeda Y; Cataliotti A; Bailey K; Rodeheffer R; Burnett JC
J Am Coll Cardiol; 2011 Mar; 57(12):1386-95. PubMed ID: 21414536
[TBL] [Abstract][Full Text] [Related]
38. [The diagnostic value of N-terminal B-type natriuretic peptide in diastolic heart failure: comparison with echocardiographic findings].
Tuğcu A; Yildirimtürk O; Aytekin S
Turk Kardiyol Dern Ars; 2009 Mar; 37(2):112-21. PubMed ID: 19404033
[TBL] [Abstract][Full Text] [Related]
39. Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC]).
Mishra RK; Li Y; Ricardo AC; Yang W; Keane M; Cuevas M; Christenson R; deFilippi C; Chen J; He J; Kallem RR; Raj DS; Schelling JR; Wright J; Go AS; Shlipak MG;
Am J Cardiol; 2013 Feb; 111(3):432-8. PubMed ID: 23178053
[TBL] [Abstract][Full Text] [Related]
40. N-terminal-probrain natriuretic peptide and echocardiography in patients with systolic heart failure.
Al-Meslmani BM; Fahoum SK; Shamia MG
Saudi Med J; 2005 Nov; 26(11):1695-8. PubMed ID: 16311650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
